PIK3CA and hereditary clear cell renal cell carcinoma: A mutation in the helical domain of PIK3CA (p.E542K), which is known to be constitutively activating and selectively sensitive to everolimus [14], was found in a renal cell carcinoma patient with the PFS of 23.9 months.